Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Presentation THT 2025

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Presenter: Milton Packer

February 12, 2025

A Strategy That Has Created More Confusion Than Clarity.

Presentation THT 2025

A Strategy That Has Created More Confusion Than Clarity.

Presenter: Milton Packer

February 11, 2025

Obesity: Assessing the Weight of the Evidence

Presentation THT 2025

Obesity: Assessing the Weight of the Evidence

Presenter: Milton Packer

February 11, 2025

Presentation AHA 2024

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Presenter: Milton Packer

November 16, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

Debating the Role of T-TEER in the Sickest Patients

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

3000 Years in the Making: Traditional Chinese Herbal Medicines for Heart Failure

Presentation THT 2024

3000 Years in the Making: Traditional Chinese Herbal Medicines for Heart Failure

Presenter: Milton Packer

March 04, 2024

SGLT2 Inhibitors Have a Unique Mechanism That Accounts for Their Comprehensive Benefits

Presentation THT 2023

SGLT2 Inhibitors Have a Unique Mechanism That Accounts for Their Comprehensive Benefits

Presenter: Milton Packer

March 20, 2023

Featured Lecture: How to Incorporate New Therapies and In What Order -- Ahead of the Guidelines

Presentation THT 2022

Featured Lecture: How to Incorporate New Therapies and In What Order -- Ahead of the Guidelines

Presenter: Milton Packer

February 01, 2022

Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse

News Daily News

Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse

January 21, 2022

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

News Features

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

October 08, 2021

TCTMD’s Top 10 Most Popular Stories for September 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2021

October 01, 2021

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

News Conference News HFSA 2021

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

September 13, 2021

EMPEROR-Preserved: Empagliflozin Improves Outcomes in HFpEF

News Conference News ESC 2021

EMPEROR-Preserved: Empagliflozin Improves Outcomes in HFpEF

August 27, 2021

Optimizing Medical Therapy Before Clip Repair for MR? ‘This is Hard’

News Conference News TVT 2021

Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’

July 27, 2021

There Is No Such Thing as Maximally-Tolerated GDMT: Use a Real-world Approach!

Presentation TVT 2021

There Is No Such Thing as Maximally-Tolerated GDMT: Use a Real-world Approach!

Presenter: Milton Packer

July 20, 2021

Echo Features Pinpoint Those Unlikely to Benefit From MitraClip

News Daily News

Echo Features Pinpoint Those Unlikely to Benefit From MitraClip

December 15, 2020

EMPEROR Reduced

Podcast TCTMD Talking Points

EMPEROR Reduced

October 21, 2020

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

News Conference News ESC 2020

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

Michael O'Riordan

August 28, 2020

When Trials Disagree: The COAPT/MITRA-FR Case Study

Presentation TCT 2019

When Trials Disagree: The COAPT/MITRA-FR Case Study

Presenter: Milton Packer

September 28, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.